Self-monitoring of blood glucose in tablet-treated type 2 diabetic patients (ZODIAC-17)

Netherlands Journal of Medicine

Volumn 68, Issue 7-8, 2010, Pages 311-316

  Kleefstra, N ^a   Hortensius, J ^a   Logtenberg, S J J ^a   Slingerl, R J ^a   Groenier, K H ^b   Houweling, S T ^a,c   Gans, R O B ^d   van Ballegooie, E ^a   Bilo, H J G ^a,d  

^a ISALA HOSPITAL   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c General Practice Sleeuwijk ^*  (Netherlands)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Blood glucose self monitoring; Diabetes mellitus type 2; Glycosylated; Haemoglobin AIC; Quality of life

Indexed keywords

HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL ARTICLE; FEMALE; GLYCEMIC CONTROL; GROUPS BY AGE; HEALTH SURVEY; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT SATISFACTION; QUALITY OF LIFE; QUESTIONNAIRE; SELF MONITORING; WELLBEING;

ADOLESCENT; ADULT; AGED; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; CONFIDENCE INTERVALS; DIABETES MELLITUS, TYPE 2; FEMALE; HEALTH STATUS INDICATORS; HEALTH SURVEYS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; METFORMIN; MIDDLE AGED; OUTPATIENTS; PATIENT SATISFACTION; QUALITY OF LIFE; QUESTIONNAIRES; TABLETS; WORLD HEALTH ORGANIZATION; YOUNG ADULT;

EID: 77957736862     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Goldstein DE, Little RR, Lorenz RA, et al. Tests of glycemia in diabetes. Diab Care. 2004;27:1761-73.
2. Nathan DM, McKitrick C, Larkin M, Schaffran R, Singer DE. Glycemic control in diabetes mellitus: have changes in therapy made a difference? Am J Med. 1996;100:157-63.
3. Karter AJ, Ackerson LM, Darbinian JA, et al. Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry. Am J Med. 2001;111:1-9.
4. Welschen LM, Bloemendal E, Nijpels G, et al. Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin. Cochrane Database Syst Rev 2005;18: CD005060.
5. Kleefstra N, Houweling ST, van Ballegooie E, Bilo HJ. Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: response to Welschen et al. Diab Care. 2005;28:2596.
6. Allen BT, DeLong ER, Feussner JR. Impact of glucose self-monitoring on non-insulin-treated patients with type II diabetes mellitus. Randomised controlled trial comparing blood and urine testing. Diab Care. 1990;13:1044-50.
7. Davidson MB, Castellanos M, Kain D, Duran P. The effect of self monitoring of blood glucose concentrations on glycated hemoglobin levels in diabetic patients not taking insulin: a blinded, randomized trial. Am J Med. 2005;118:422-5.
8. Ubink-Veltmaat LJ, Bilo HJ, Groenier KH, Houweling ST, Rischen RO, Meyboom-de Jong B. Prevalence, incidence and mortality of type 2 diabetes mellitus revisited: a prospective population-based study in The Netherlands (ZODIAC-1). Eur J Epidemiol. 2003;18:793-800. Kleefstra, et al. SMBG in non-insulin treated type 2 diabetes.
9. Keller SD, Ware JE Jr, Bentler PM, et al. Use of structural equation modeling to test the construct validity of the SF-36 Health Survey in ten countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol. 1998;51:1179-88.
10. Aaronson NK, Muller M, Cohen PD, et al. Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. Clin Epidemiol. 1998;51:1055-68.
11. Ware JE, Gandek B. For the IQOLA Project. Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project. J Clin Epidemiol. 1998;51:903-12.
12. De Wit M, Pouwer F, Gemke RJ, Delemarre-van de Waal HA, Snoek FJ. Validation of the WHO-5 Well-Being Index in adolescents with type 1 diabetes. Diab Care. 2007;30:2003-6.
13. Bech P, Olsen LR, Kjoller M, Rasmussen NK. Measuring well-being rather than the absence of distress symptoms: a comparison of the SF-36 Mental Health subscale and the WHO-Five Well-Being Scale. Int J Methods Psychiatr Res. 2003;12:85-91.
14. Bradley C, Lewis KS. Measures of psychological well-being and treatment satisfaction developed from the responses of people with tablet-treated diabetes. Diabet Med. 1990;7:445-51.
15. Grootenhuis PA, Snoek FJ, Heine RJ, Bouter LM. Development of a type 2 diabetes symptom checklist: a measure of symptom severity. Diabet Med. 1994;11:253-61.
16. Farmer A, Wade A, Goyder E, et al. Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial. BMJ. 2007;335:132.
17. O'Kane MJ, Bunting B, Copeland M, Coates VE; ESMON study group. Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial. BMJ. 2008;336:1174-7.
18. Barnett AH, Krentz AJ, Strojek K, et al. The efficacy of self-monitoring of blood glucose in the management of patients with type 2 diabetes treated with a gliclazide modified release-based regimen. A multicentre, randomized, parallel-group, 6-month evaluation (DINAMIC-1 study). Diab Obes Metabol. 2008;10:1239-47.
19. Kleefstra N, Hortensius J, van Hateren KJ, et al. Self-monitoring of blood glucose in non-insulin-treated type 2 diabetes: an overview. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2009;2:155-63.
20. Rutten GEHM, Grauw WJC de, Nijpels G, et al. NHG-Standaard Diabetes mellitus type 2. Huisarts Wet. 2006;49:137-52.
21. Ellis SE, Speroff T, Dittus RS, Brown A, Pichert JW, Elasy TA. Diabetes patient education: a meta-analysis and meta-regression. Patient Educ Couns. 2004;52:97-105.